esophagus cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. >= 18 years old. 2. The subjects have undergone or plan to undergo esophageal endoscopy and can obtain the endoscopy results or histopathological test results. 3. Agree to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Breastfeeding or pregnant women; 2. Individuals with a history of esophageal cancer; 3. Those who have previously received therapeutic interventions for esophageal cancer, such as surgery, radiotherapy, chemotherapy, targeted therapy, immunotherapy, etc.; 4. Patients with other primary malignant tumors within the past 5 years (patients who have been diagnosed with other cancers, treated and stable for over 5 years may be included); 5. Individuals with severe cardiac, pulmonary, hepatic, renal insufficiency or other serious systemic diseases; 6. Patients with infectious diseases, such as hepatitis B, hepatitis C, HIV infection, etc.; 7. Those with mental disorders or psychological diseases that make it impossible to comply with study requirements; 8. Individuals who cannot meet the study's testing requirements due to sampling issues; 9. Other individuals deemed unsuitable for participation in this clinical trial by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AUC;sensitivity;specificity; | — |
Countries
China
Contacts
The First Affiliated Hospital of Xiamen University